Menu UF Health Home Menu
 

David Markusic, Ph.D.

David MarkusicDivision

Cellular and Molecular Therapy

Academic Title

Research Assistant Professor

Contact Information

352-273-8079 (phone)
dmarkusic@ufl.edu

Lab

Cancer and Genetics Research Complex, Room 230G

Training

University of Amsterdam, The Netherlands 2000-2007

  • PhD – Lentiviral vectors for regulated and liver directed gene therapy 2007
  • MSc – Molecular Biology 2002

Research Overview

Using novel adeno-associate virus (AAV) vectors for gene therapy to treat hemophilia.  To model and identify strategies to minimize immune responses against human factor IX protein and AAV following gene transfer. To translate effective strategies in hemophilia models that induce tolerance and reverse pre-existing immunity to coagulator factor to treat autoimmune disease.

Key Publications

View a complete list of publications on PubMed

  1. Markusic DM, Hoffman BE, Perrin GQ, Nayak S, Wang X, Loduca PA, High KA, Herzog RW. Effective gene therapy for haemophilic mice with pathogenic factor IX antibodies. EMBO Mol Med. 2013 Nov;5(11):1698-709. doi: 10.1002/emmm.201302859. Epub 2013 Sep 16. PubMed PMID: 24106230; PubMed Central PMCID: PMC3840486.
  2. Martino AT, Basner-Tschakarjan E, Markusic DM, Finn JD, Hinderer C, Zhou S, Ostrov DA, Srivastava A, Ertl HC, Terhorst C, High KA, Mingozzi F, Herzog RW. Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells. Blood. 2013 Mar 21;121(12):2224-33. doi: 10.1182/blood-2012-10-460733. Epub 2013 Jan 16. PubMed PMID: 23325831; PubMed
    Central PMCID: PMC3606062.
  3. Sack BK, Merchant S, Markusic DM, Nathwani AC, Davidoff AM, Byrne BJ, Herzog RW. Transient B cell depletion or improved transgene expression by codon optimization promote tolerance to factor VIII in gene therapy. PLoS One. 2012;7(5):e37671. doi: 10.1371/journal.pone.0037671. Epub 2012 May 24. PubMed PMID: 22655063; PubMed Central PMCID: PMC3359994.
  4. Markusic DM, Herzog RW. Liver-Directed Adeno-Associated Viral Gene Therapy for Hemophilia. J Genet Syndr Gene Ther. 2012 Jan 18;1:1-9. PubMed PMID: 23565343; PubMed Central PMCID: PMC3615444.
  5. Herzog RW, Davidoff AM, Markusic DM, Nathwani AC. AAV vector biology in primates: finding the missing link? Mol Ther. 2011 Nov;19(11):1923-4. doi: 10.1038/mt.2011.218. PubMed PMID: 22051598; PubMed Central PMCID: PMC3222536.Moghimi, B, Sack, BK, Nayak, S, Markusic, DM, Mah, CS, and Herzog, RW (2011). Tolerance Induction to Factor VIII by Transient Co-administration with Rapamycin. J Thromb Haemost.  9: 1524-1533.
  6. Martino AT, Suzuki M, Markusic DM, Zolotukhin I, Ryals RC, Moghimi B, Ertl HC, Muruve DA, Lee B, Herzog RW. (2011). The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver. Blood 117: 6459-6468.
  7. May T, Butueva M, Bantner S, Markusic D, Seppen J, MacLeod RA, Weich H, Hauser H, Wirth D. (2010). Synthetic gene regulation circuits for control of cell expansion. Tissue Eng Part A 16: 441-452.
  8. Markusic DM, Herzog RW, Aslanidi GV, Hoffman BE, Li B, Li M, Jayandharan GR, Ling C, Zolotukhin I, Ma W, Zolotukhin S, Srivastava A, Zhong L. (2010). High-efficiency Transduction and Correction of Murine Hemophilia B Using AAV2 Vectors Devoid of Multiple Surface-exposed Tyrosines. Mol Ther. 12: 2048-56
  9. Markusic, DM, de Waart, DR, and Seppen, J (2010). Separating lentiviral vector injection and induction of gene expression in time, does not prevent an immune response to rtTA in rats. PLoS One 5: e9974.
  10. Markusic, D, and Seppen, J (2010). Doxycycline regulated lentiviral vectors. Methods Mol Biol 614: 69-76.
  11. Martino AT, Nayak S, Hoffman BE, Cooper M, Liao G, Markusic DM, Byrne BJ, Terhorst C, Herzog RW. (2009). Tolerance induction to cytoplasmic beta-galactosidase by hepatic AAV gene transfer: implications for antigen presentation and immunotoxicity. PLoS One 4: e6376.
  12. Markusic, DM, van Til, NP, Hiralall, JK, Elferink, RP, and Seppen, J (2009). Reduction of liver macrophage transduction by pseudotyping lentiviral vectors with a fusion envelope from Autographa californica GP64 and Sendai virus F2 domain. BMC Biotechnol 9: 85.